Found "Public health policy": 1,044 results
Drug procurement in public hospitals under the Government Procurement and Supplies Management Act B.E. 2560
Project ConsultantSripen TantivessPattara LeelahavarongNetnapis Suchonwanich59002017R2021L4Drug procurement,price performance,public hospital,พระราชบัญญัติการจัดซื้อจัดจ้างและการบริหารพัสดุภาครัฐ
Drug Maker Seeks Protection Within Bill Favoring Generics
WASHINGTON — One of the few bills moving through Congress with bipartisan support this spring would speed government approval of lower-cost generic copies of brand-name drugs. But one company, with help from an influential former congressman, is lobbying to protect its most lucrative brand-name prod
Drug Approved to Fight H.I.V. Infection
The Food and Drug Administration on Monday approved the first drug shown to reduce the risk of H.I.V. infection, a milestone in the 30-year battle against the virus that causes AIDS. The agency approved Truvada, a pill made by Gilead Sciences, as a preventive measure for people who are at high risk
Driving sobriety tests likely to miss medical pot
(Reuters Health) – A new, small study suggests medicinal marijuana may impair users’ driving skills – but might be missed by typical sobriety tests.At doses used in AIDS, cancer and pain patients, people weaved side to side more and had a slower reaction time in the hours after using the drug, resea
Dr. Wang Yi
Asst. Prof. Dr. Wang Yi is a co-founder of Medical Innovation Development and Assessment Support (MIDAS). His research areas include early health technology assessment, traditional health technology assessment, population’s preference for health and healthcare, and economic evaluation/analysis using real-world data and observational data. He is als
Dr. Teerawat Wiwatpanit
Dr. Teerawat Wiwatpanit is a biomedical scientist by training. His expertise includes early health technology assessment, innovation development, and biomedical engineering for disease modeling and drug testing. He is passionate about promoting an efficient innovation landscape and translating scientific discoveries into practical healthcare soluti
Dr. Nishanta Sharma
Dr. Nishanta Sharma is a quantitative researcher at HITAP Thailand, currently leading a project that assesses the environmental and economic impacts of low-value healthcare services using input-output analysis, as well as exploring the nexus between climate and epidemiology. He holds a PhD in Development and Sustainability from the Asian Institute
Dr. Joshua Randall Freeman
Joshua R. Freeman, Ph.D., M.P.H., is a Researcher in the Research International Unit of the HITAP Foundation. He holds a Ph.D. in Epidemiology and an M.P.H. in Public Health. His research focuses on sleep health throughout the life course, investigating how sleep patterns and circadian rhythms influence health outcomes, and contributing to evidence
Dr. Arpaporn Sutipatanasomboon
Dr. Arpaporn Sutipatanasomboon is experienced in cell biology and molecular genetics research and is a registered patent agent with the Thailand Department of Intellectual Property. Her passion is to integrate early health technology assessment and intellectual property management to support decision makers, innovators and promote access to innovat
Dr Dillner’s health dilemmas: should I give herbal remedies to my children?
Echinacea, a favourite herbal remedy for parents to give children with the sniffles, should not be given to the under-12s, said the Medicine and Healthcare Products Regulatory Agency last week.The herb, said to reduce symptoms of colds by boosting scavenger cells called macrophages in the immune sys
10 / Page